Seelos Therapeutics, Inc.
SEELDelisted Apr 4, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001017491
Seelos Therapeutics, Inc. was delisted on Apr 4, 2025; its insiders filed their last Form 4 on Mar 1, 2024; 23 institutions reported holding it in 13F filings for Q2 2024, worth $129.4K in total; no superinvestor held it.
13F holders, Q3 2024
Institutional positions in Seelos Therapeutics, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
SEEL is no longer listed, and 13F filings after Q2 2024 list far fewer holders. See Q2 2024
- Institutional holders
- 15
- −7 vs. Q2 2024
- Shares held
- 38.7K
- +25.8K (+199.7%) vs. Q2 2024Converted for a 1-for-16 split
- Total value
- $145.2K
- +$20.0K (+15.9%) vs. Q2 2024
- New holders
- 2
- 4 more added
- Sold out
- 9
- 9 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SEEL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 1 | $0 |
| Q4 2025 | 1 | $0 |
| Q3 2025 | 1 | $0 |
| Q2 2025 | 1 | $0 |
| Q1 2025 | 1 | $0 |
| Q4 2024 | 3 | $4.77K |
| Q3 2024 | 15 | $145.2K |
| Q2 2024 | 23 | $129.4K |
| Q1 2024 | 36 | $1.55M |
| Q4 2023 | 39 | $2.48M |
| Q3 2023 | 82 | $7.01M |
| Q2 2023 | 83 | $27.1M |
| Q1 2023 | 80 | $15.1M |
| Q4 2022 | 80 | $15.6M |
| Q3 2022 | 85 | $28.0M |
| Q2 2022 | 86 | $21.3M |
| Q1 2022 | 92 | $33.0M |
| Q4 2021 | 97 | $65.9M |
| Q3 2021 | 110 | $98.2M |
| Q2 2021 | 105 | $107.8M |
| Q1 2021 | 73 | $124.8M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Seelos Therapeutics, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| AdvisorShares Investments LLC | 18,113 | $68.0K | 0.01% | +12,500+222.7% | AddedConverted for a 1-for-16 split |
| Modera Wealth Management, LLC | 10,805 | $40.6K | 0.00% | +9,472+710.3% | AddedConverted for a 1-for-16 split |
| UBS Group AG | 8,477 | $31.8K | 0.00% | +8,474+271,164.0% | AddedConverted for a 1-for-16 split |
| Morgan Stanley | 675 | $2.54K | 0.00% | −717−51.5% | ReducedConverted for a 1-for-16 split |
| BlackRock, Inc. | 354 | $1.33K | 0.00% | +354 | New |
| Tower Research Capital LLC (TRC) | 95 | $357 | 0.00% | −146−60.6% | ReducedConverted for a 1-for-16 split |
| Carmichael Hill & Associates, Inc. | 62 | $233 | 0.00% | −1−0.8% | ReducedConverted for a 1-for-16 split |
| Bank of America Corp | 32 | $120 | 0.00% | +3+8.5% | AddedConverted for a 1-for-16 split |
| JPMorgan Chase & Co | 31 | $116 | 0.00% | −0−1.0% | ReducedConverted for a 1-for-16 split |
| Group One Trading, L.P. | 12 | $45 | 0.00% | −2−11.1% | ReducedConverted for a 1-for-16 split |
| Crewe Advisors LLC | 7 | $27 | 0.00% | −0−2.6% | ReducedConverted for a 1-for-16 split |
| Vermillion & White Wealth Management Group, LLC | 7 | $26 | 0.00% | −1−8.9% | ReducedConverted for a 1-for-16 split |
| Wells Fargo & Company | 2 | $8 | 0.00% | −1−22.0% | ReducedConverted for a 1-for-16 split |
| Danske Bank A/S | 2 | $8 | 0.00% | +2 | New |
| Newbridge Financial Services Group, Inc. | 1 | $4 | 0.00% | −1−33.3% | ReducedConverted for a 1-for-16 split |
| Wealth Effects LLC | 0 | $0 | 0.00% | −3,365−100.0% | Sold outConverted for a 1-for-16 split |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −800−100.0% | Sold outConverted for a 1-for-16 split |
| Hollencrest Capital Management | 0 | $0 | 0.00% | −1−100.0% | Sold outConverted for a 1-for-16 split |
| TD Waterhouse Canada Inc. | 0 | $0 | 0.00% | −1−100.0% | Sold outConverted for a 1-for-16 split |
| The PNC Financial Services Group, Inc. | 0 | $0 | 0.00% | −0−100.0% | Sold outConverted for a 1-for-16 split |
| National Bank of Canada | 0 | $0 | 0.00% | −0−100.0% | Sold outConverted for a 1-for-16 split |
| Westside Investment Management, Inc. | 0 | $0 | 0.00% | −0−100.0% | Sold outConverted for a 1-for-16 split |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −0−100.0% | Sold outConverted for a 1-for-16 split |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −0−100.0% | Sold outConverted for a 1-for-16 split |
| BlackRock Inc. | – | – | – | – | Not filed |